Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2014
10/14/2014US8859789 Method for producing optically active fluorine-containing oxeten
10/14/2014US8859776 Substituted piperidines that increase p53 activity and the uses thereof
10/14/2014US8859611 Thiophene inhibitors of S-nitrosoglutathione reductase
10/14/2014US8859602 Inhibitors of c-fms kinase
10/14/2014US8859596 Compounds as cannabinoid receptor ligands
10/14/2014US8859588 Substituted N-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
10/14/2014US8859574 Compounds and compositions as kinase inhibitors
10/14/2014US8859546 Picolinamide inhibitors of kinases
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859535 Hydroxy substituted isoquinolinone derivatives
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014165127A1 Pyrrole amide inhibitors
10/09/2014WO2014164286A1 Dual sglt1/sglt2 inhibitors
10/09/2014WO2014161888A1 N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
10/09/2014WO2014161808A1 Novel n-(2,3-dihydro-1h-pyrrolo[2,3-b]jpyridin-5-yl)-4- quinazolinamine and n-(2,3-dihydro-1h-indol-5-yl)-4- quinazolinamine derivatives as perk inhibitors
10/09/2014US20140303372 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
10/09/2014US20140303207 Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes Methods For Their Preparation And Their Use As Medicaments
10/09/2014US20140303182 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/09/2014US20140303171 Hiv protease inhibitors
10/09/2014US20140303160 Targeting GLI Proteins in Human Cancer by Small Molecules
10/09/2014US20140303156 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303127 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2785694A1 N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853392 Benzamide mGluR5 positive allosteric modulators and methods of making and using same
10/07/2014US8853244 Thiophene-carboxamides useful as inhibitors of protein kinases
10/07/2014US8853214 Pyridazine compounds for controlling invertebrate pests
10/07/2014US8853205 Heteropyrrole analogs acting on cannabinoid receptors
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/07/2014US8853196 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy
10/07/2014US8852937 Small organic molecule regulators of cell proliferation
10/07/2014US8852759 Compound having acridan ring structure, and organic electroluminescent device
10/02/2014WO2014160649A1 Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014160401A1 3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
10/02/2014WO2014159657A1 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157687A1 1,2,4-triazine-6-carboxamide derivative with acetamide group
10/02/2014WO2014157672A1 Substituted biaryl compound
10/02/2014WO2014157574A1 Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device
10/02/2014WO2014157382A1 Sphingosine kinase inhibitor
10/02/2014WO2014157371A1 Novel imidazole compound, material for electronic devices, light emitting element, electronic device and method for manufacturing electronic device
10/02/2014WO2014157009A1 Photoelectric conversion element, imaging element and optical sensor
10/02/2014WO2014154794A1 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
10/02/2014WO2014153624A1 Antibacterial compounds
10/02/2014US20140296531 Novel semi-synthetic small molecules for the treatment parasitic disease
10/02/2014US20140296514 Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/02/2014US20140296287 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
10/02/2014US20140296256 Plasminogen activator inhibitor-1 inhibitor
10/02/2014US20140296254 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
10/02/2014US20140296228 Inhibitors of human immunodeficiency virus replication
10/02/2014US20140296215 Cyanoquinoline Compounds Having Activity in Correcting Mutant-Cftr Processing and Increasing Ion Transport and Uses Thereof
10/02/2014US20140296206 Compositions useful for treating disorders related to kit
09/2014
09/30/2014US8846955 Second-order nonlinear optical compound and nonlinear optical element comprising the same
09/30/2014US8846933 N-link hydroxamic acid derivatives useful as antibacterial agents
09/30/2014US8846912 Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/30/2014US8846906 5HT2C receptor modulators
09/30/2014US8846749 Anticancer-aiding compound, method for preparing the same, anticancer-aiding composition containing the same and method for reducing anticancer drug resistance using the same
09/30/2014US8846746 Pyrazole compound and pharmaceutical use thereof
09/30/2014US8846736 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
09/30/2014US8846727 Haloalkyl heteroaryl benzamide compounds
09/30/2014US8846705 Diaminopyrimidines as P2X3 and P2X2/3 antagonists
09/30/2014US8846681 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
09/30/2014US8846677 Medicaments
09/30/2014US8846660 Seven-membered ring compound and pharmaceutical use therefor
09/30/2014US8846655 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
09/30/2014CA2664579C 2-aminocarbonyl-pyridine derivatives
09/25/2014WO2014153214A1 Arginine methyl transferase inhibtors and uses thereof
09/25/2014WO2014152134A1 Tripeptide epoxy ketone protease inhibitors
09/25/2014WO2014152127A1 Dipeptide and tripeptide epoxy ketone protease inhibitors
09/25/2014WO2014150981A1 Inhibitors of lrrk2 kinase activity
09/25/2014WO2014147642A1 Substituted fluoranthene-7-carbonitriles as fluorescent dyes for cell imaging applications
09/25/2014US20140288300 Drug-fluorophore complex for specific detection of tumor cells
09/25/2014US20140288127 Novel Alkene Oxindole Derivatives
09/25/2014US20140288105 Arginine methyltransferase inhibitors and uses thereof
09/25/2014US20140288088 Inhibitors of the Renal Outer Medullary Potassium Channel
09/25/2014US20140288076 Heteroaryl compounds and their uses
09/25/2014US20140288065 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/25/2014US20140288049 2-Thiopyrimidinones
09/25/2014US20140288044 Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors
09/24/2014EP2781510A1 HIV inhibiting 5,6-substituted pyrimidines
09/24/2014EP2780339A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
09/24/2014EP2780332A1 Morpholinyl benzotriazine for use in cancer therapy
09/23/2014US8841450 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841449 Compounds useful as inhibitors of ATR kinase
09/23/2014US8841340 Solid forms of an antiviral compound
09/23/2014US8841336 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
09/23/2014US8841278 Antiviral compounds
09/23/2014CA2582347C Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
09/23/2014CA2575853C Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
09/18/2014WO2014146059A1 Halogenopyrazoles as inhibitors of thrombin
09/18/2014WO2014144500A2 Methods of synthesizing a difluorolactam analog
09/18/2014WO2014144169A1 Carm1 inhibitors and uses thereof
09/18/2014WO2014142322A1 Benzothiophene derivative
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014141177A1 New arylaminoalcohol derivatives with antiplasmodial activity
09/18/2014WO2014141015A1 Pyrazolylbenzo[d]imidazole derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 523